Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC73513 | RGH-122 |
RGH-122 is a potent, selective, and orally bioavailable V1a receptor antagonist with Ki/IC50 of 0.3/0.9 nM (hV1a) respectively, >100-fold selectiive over V2 receptor.
More description
|
![]() |
DC73512 | OPC-61815 |
OPC-61815 is a water-soluble phosphate ester pro-drug of Tolvaptan (Cat# PC-45125), which is an orally active vasopressin V2 receptor antagonist.
More description
|
![]() |
DC70087 | Desmopressin Featured |
Desmopressin is a synthetic analogue of the antidiuretic hormone arginine vasopressin.
More description
|
![]() |
DC11516 | Balovaptan Featured |
Balovaptan (RG7314, RG-7314) is a potent, selective vasopressin-1 receptor antagonist..
More description
|
![]() |
DC72348 | Selepressin |
Selepressin (FE 202158) is a selective vasopressin V1A receptor agonist. Selepressin is a potent vasopressor. Selepressin can be used in the research of septic shock.
More description
|
![]() |
DC10583 | RO 5028442 Featured |
RO5028442 is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a).
More description
|
![]() |
DC9637 | Desmopressin (Acetate) Featured |
Desmopressin(DDAVP) acetate is the synthetic analogue of the antidiuretic hormone arginine vasopressin.
More description
|
![]() |
DCAPI1091 | Conivaptan hydrochloride Featured |
Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.
More description
|
![]() |
DC48979 | TASP0390325 |
TASP0390325 is a high affinity and orally active arginine vasopressin receptor 1B (V1B receptor) antagonist with antidepressant and anxiolytic activities.
More description
|
![]() |
DC9148 | Tolvaptan Featured |
Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.
More description
|
![]() |
DC47092 | Lazuvapagon |
Lazuvapagon is a vasopressin V2 receptor agonist for the research of nocturia.
More description
|
![]() |
DC47063 | Enuvaptan |
Enuvaptan is a vasopressin receptor antagonist and has the potential for research into renal and cardiovascular diseases.
More description
|
![]() |
DC42504 | SKF 100398 |
SKF 100398 (d(CH2)5Tyr(Et)VAVP) is an arginine vasopressin (AVP) analogue, and acts as a specific antagonist of the antidiuretic effect of exogenous and endogenous AVP.
More description
|
![]() |
DC42041 | Big Endothelin-1 (1-39), porcine |
Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1. Endothelin-1 (ET-1) is a potent vasopressor peptide. Big Endothelin-1 (1-39), porcine has similar pressor effects in vivo.
More description
|
![]() |
DC42040 | Big Endothelin-1 (1-38), human |
Big Endothelin-1 (1-38), human is the precursor of endothelin-1. Endothelin-1 (ET-1) is a potent vasopressor peptide.
More description
|
![]() |
DC41823 | d[Cha4]-AVP TFA |
d[Cha4]-AVP TFA is a potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). d[Cha4]-AVP TFA stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo.
More description
|
![]() |
DC41822 | d[Cha4]-AVP |
d[Cha4]-AVP is a potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). d[Cha4]-AVP stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo.
More description
|
![]() |
DC41635 | Antagonist G TFA |
Antagonist G TFA is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
More description
|
![]() |
DC41623 | D[LEU4,LYS8]-VP TFA |
D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities.
More description
|
![]() |
DC41622 | D[LEU4,LYS8]-VP |
D[LEU4,LYS8]-VP is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP has weak antidiuretic, vasopressor, and in vitro oxytocic activities.
More description
|
![]() |
DC40339 | Terlipressin acetate |
Terlipressin acetate is a vasopressin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
More description
|
![]() |
DC28173 | SRX246 |
SRX246 is a potent, CNS-penetrant, highly selective, orally bioavailable vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V1a). SRX246 has no interaction at V1b and V2 receptors. SRX246 also displays negligible binding at 64 others receptors classes, including 35 G-proteincoupled receptors. SRX246 can be used for treatment of stress-related disorders.
More description
|
![]() |
DC10326 | Mozavaptan |
Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM.
More description
|
|